The Blue Cross Blue Shield Association's $2.67 billion antitrust class action settlement entered its distribution phase in May 2026, with payments beginning to reach approximately 6 million eligible policyholders who submitted claims [1][2]. After deductions for attorneys' fees and administrative costs, roughly $1.9 billion remains available for distribution, yielding an estimated average payout of approximately $333 per approved claim [1][2].
The settlement resolves consolidated antitrust claims brought in the Northern District of Alabama under MDL 2406, in which subscriber plaintiffs alleged that BCBS member plans coordinated to suppress competition among health insurers, artificially limiting coverage options and inflating premium costs [1]. The original settlement agreement was reached in October 2020, with the court granting final approval thereafter [2]. The case proceeded under federal antitrust law, specifically Sherman Act claims targeting the association's BlueCard program and the allocation of geographic service territories among member plans, arrangements plaintiffs argued constituted horizontal market division [1]. The settlement class covered individual and fully insured group policyholders who purchased or were enrolled in BCBS plans during the covered period.
The litigation's path from filing to distribution spans more than a decade. Plaintiffs first filed suit in 2012, and the case consolidated numerous individual and class actions before a single federal judge in Birmingham, Alabama [1]. The court's approval of the settlement structure and class certification presented significant complexity, given the nationwide scope of the class and the number of BCBS-affiliated plans named as defendants. The distribution phase, now underway, is administered through the official settlement administrator operating the bcbssettlement.com portal [2].
The May 2026 payment commencement is the final procedural milestone remaining for most claimants. Individuals who submitted timely claims during the filing window are receiving payment via the method selected at the time of submission [1][2]. No further claim submissions are available at this stage. The case stands as one of the largest antitrust settlements in the history of the U.S. health insurance industry, and its distribution mechanics may inform how future large-scale antitrust class actions structure administration and disbursement in similarly fragmented insurance markets.
Comments (0)